NextPlat (NASDAQ:NXPL) Issues Quarterly Earnings Results

NextPlat (NASDAQ:NXPL) posted its earnings results on Tuesday. The company reported ($0.24) earnings per share for the quarter, FiscalAI reports. NextPlat had a negative return on equity of 34.22% and a negative net margin of 14.58%.The business had revenue of $12.81 million for the quarter.

Here are the key takeaways from NextPlat’s conference call:

• The company completed a reverse split to maintain its Nasdaq listing; management says it was necessary but acknowledges investor negativity despite stating NextPlat has ~$14 million in cash, no debt, and high insider ownership.
• Healthcare showed an early turnaround — 340B contract revenue rose 94% sequentially in Q4, medication fulfillment now exceeds 7,000 prescriptions/month, and a new HealthWarehouse partnership enables expansion from Florida to all 50 states.
• Management implemented >$2 million in annualized cost reductions and cut operating expenses ~25% (salaries down ~20%, professional fees down ~49%), ending the year with strong liquidity and expecting substantially reduced cash burn in 2026.
• Full-year revenue declined ~18% to ~$54 million (healthcare down to ~$40 million from $52M) and consolidated gross margin fell to ~20% from 26% in 2024, though management reports sequential margin improvement and expects gradual recovery in 2026.
• E-commerce remained a growth engine — revenue rose ~6% to ~$15 million, with record device sales, higher recurring airtime revenue, new distribution agreements, defense/NATO contracts, and launches on Mercado Libre in five South American countries.

NextPlat Stock Up 5.1%

Shares of NXPL stock opened at $0.39 on Thursday. NextPlat has a 12-month low of $0.34 and a 12-month high of $1.11. The company has a quick ratio of 2.80, a current ratio of 3.56 and a debt-to-equity ratio of 0.04. The firm has a fifty day moving average of $0.54 and a 200-day moving average of $0.65. The company has a market capitalization of $10.57 million, a price-to-earnings ratio of -0.89 and a beta of 1.38.

NextPlat shares are scheduled to reverse split on the morning of Monday, April 6th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, April 5th.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new stake in NextPlat Corp. (NASDAQ:NXPL) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat as of its most recent filing with the SEC. Hedge funds and other institutional investors own 1.30% of the company’s stock.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NextPlat in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.